Cargando…
Therapeutic potentials of fasudil in liver fibrosis
Fasudil has the potential to prevent liver fibrosis by activating natural killer cells and inhibiting the proliferation of hepatic stellate cells. Fasudil may be a promising clinical therapeutic drug for the prevention and treatment of liver fibrosis.
Autores principales: | Xi, Yue, Xu, Peng-Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661378/ https://www.ncbi.nlm.nih.gov/pubmed/34963748 http://dx.doi.org/10.3748/wjg.v27.i45.7859 |
Ejemplares similares
-
Nasal delivery of Fasudil‐modified immune cells exhibits therapeutic potential in experimental autoimmune encephalomyelitis
por: Guo, Shang‐De, et al.
Publicado: (2019) -
Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells
por: Han, Qiu-Ju, et al.
Publicado: (2021) -
Fasudil, a Rho-Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Jiang, Chunguo, et al.
Publicado: (2012) -
Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstruction
por: BABA, ITSUKO, et al.
Publicado: (2015) -
Epithelial-Mesenchymal Transition: A Potential Therapeutic Goal for Prevention of Wound Fibrosis?
por: Farahani, Ramin Mostofi Zadeh
Publicado: (2006)